×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ATYR – atyr pharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ATYR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
08:00 am
atyr
aTyr Pharma to Participate in April Investor Conferences
Low
Report
aTyr Pharma to Participate in April Investor Conferences
3/27
04:00 pm
atyr
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/26
08:00 am
atyr
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
High
Report
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
3/14
03:12 pm
atyr
aTyr Pharma: Good Safety Data In Pulmonary Sarcoidosis, Institutions Are Accumulating [Seeking Alpha]
Low
Report
aTyr Pharma: Good Safety Data In Pulmonary Sarcoidosis, Institutions Are Accumulating [Seeking Alpha]
3/14
08:04 am
atyr
Atyr PHARMA INC (NASDAQ: ATYR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Low
Report
Atyr PHARMA INC (NASDAQ: ATYR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
3/13
08:07 pm
atyr
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update [Yahoo! Finance]
3/13
04:01 pm
atyr
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
Low
Report
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
3/12
04:00 pm
atyr
aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
High
Report
aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
04:15 pm
atyr
Form ARS aTYR PHARMA INC For: Dec 31
Low
Report
Form ARS aTYR PHARMA INC For: Dec 31
3/19
04:08 pm
atyr
Form DEF 14A aTYR PHARMA INC For: Mar 19
Low
Report
Form DEF 14A aTYR PHARMA INC For: Mar 19
3/17
07:08 pm
atyr
Form 4 aTYR PHARMA INC For: Mar 17 Filed by: Gross Jane A
Medium
Report
Form 4 aTYR PHARMA INC For: Mar 17 Filed by: Gross Jane A
3/13
05:19 pm
atyr
Form 10-K aTYR PHARMA INC For: Dec 31
High
Report
Form 10-K aTYR PHARMA INC For: Dec 31
3/13
04:03 pm
atyr
Form 8-K aTYR PHARMA INC For: Mar 13
Low
Report
Form 8-K aTYR PHARMA INC For: Mar 13
2/4
06:18 pm
atyr
Form 4 aTYR PHARMA INC For: Feb 03 Filed by: Shukla Sanjay
Low
Report
Form 4 aTYR PHARMA INC For: Feb 03 Filed by: Shukla Sanjay
2/4
06:14 pm
atyr
Form 4 aTYR PHARMA INC For: Feb 03 Filed by: Broadfoot Jill Marie
Low
Report
Form 4 aTYR PHARMA INC For: Feb 03 Filed by: Broadfoot Jill Marie
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: